| Literature DB >> 35284441 |
Xiao-Yan Zhuang1, Yong-Hui Zhang1, An-Feng Xiao1, Ai-Hui Zhang2, Bai-Shan Fang1,2.
Abstract
Dietary bioactive lipids, one of the three primary nutrients, is not only essential for growth and provides nutrients and energy for life's activities but can also help to guard against disease, such as Alzheimer's and cardiovascular diseases, which further strengthen the immune system and maintain many body functions. Many microorganisms, such as yeast, algae, and marine fungi, have been widely developed for dietary bioactive lipids production. These biosynthetic processes were not limited by the climate and ground, which are also responsible for superiority of shorter periods and high conversion rate. However, the production process was also exposed to the challenges of low stability, concentration, and productivity, which was derived from the limited knowledge about the critical enzyme in the metabolic pathway. Fortunately, the development of enzymatic research methods provides powerful tools to understand the catalytic process, including site-specific mutagenesis, protein dynamic simulation, and metabolic engineering technology. Thus, we review the characteristics of critical desaturase and elongase involved in the fatty acids' synthesis metabolic pathway, which aims to not only provide extensive data for enzyme rational design and modification but also provides a more profound and comprehensive understanding of the dietary bioactive lipids' synthetic process.Entities:
Keywords: bioactive lipids; desaturase; elongase; fatty acid synthesis pathway; oleogenic microorganisms
Year: 2022 PMID: 35284441 PMCID: PMC8905437 DOI: 10.3389/fnut.2022.851402
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Key enzyme in the fatty acids' synthesis pathway.
The characteristic of the desaturase in ω-6 and ω-3 pathway.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| Δ9 |
| / | 1,635 | 545 | 60.8 | XP_016270987.1 | ( |
| / | 1,182 | 394 | 45 | AMX81567.1 | ( | ||
|
| 11.9% | 1,227 | 408 | 46.36 | / | ( | |
| Δ12 |
| / | 1,158 | 386 | 42.8 | ABD58898.1 | ( |
|
| / | 1,224 | 407 | / | ABK15557.1 | ( | |
| / | 1,845 | 433 | / | ACX42440.1 | ( | ||
|
| / | 1,411 | 383 | / | AAK26633.1 | ( | |
|
| / | 1,259 | 382 | / | AAL68983.1 | ( | |
|
| / | 2,032 | 385 | / | ACF98528.1 | ( | |
|
| / | 1,526 | 436 | / | AAO23564.1 | ( | |
| Haematococcus pluvialis | / | 1,137 | 378 | 43.29 | MH817076.1 | ( | |
|
| / | 1,356 | 451 | 50.6 | XM_016420199.1 | ( | |
| Δ6 |
| 7% to ALA, 6% to LA | 1,821 | 465 | 51.9 | AAU11445.1 | ( |
|
| / | 1,380 | 459 | 52.7 | JX431892.1 | ( | |
|
| 3.14% to LA, 2.21% to ALA | 1,443 | 480 | / | JN205756.1 | ( | |
|
| / | 1,831 | 467 | / | AAR27297.1 | ( | |
|
| 60% to ALA, 10% to LA | 1,570 | 463 | 54.52 | XM_003056946.1 | ( | |
| / | 1,242 | 413 | 45 | AB847088.1 | ( | ||
| 62.7% to LA, 60.9% to ALA | 1,401 | 466 | 52.8 | ALE65995.1 | ( | ||
|
| / | 1,329 | 422 | / | / | ( | |
|
| / | 1,455 | 484 | / | AY817155.1 | ( | |
| 2.3% to LA, 6.3% to ALA | 1,478 | 482 | ~78 | KR005946.1 | ( | ||
| 1,572 | 523 | AB090360.1 | ( | ||||
| Δ5 |
| 5% to DGLA, 6% to ETA | 1,254 | 417 | / | HQ678521.1 | ( |
|
| 12% to DGLA, 12.5% to ETA | 1,341 | 446 | / | GU593328.1 | ( | |
|
| 9% to DGLA, 11% to ETA | 1,476 | 491 | / | HQ678520.1 | ( | |
|
| 6% to DGLA, 8% to ETA | 1,476 | 491 | / | HQ678519.1 | ( | |
|
| 13% to DGLA, 14% to ETA | 1,542 | 513 | / | HQ678517.1 | ( | |
| 24.8% to DGLA, 36.6% to ETA | 1,308 | 435 | 50 | AB432913.1 | ( | ||
| 19.9% to DGLA, 22.9% to ETA | 1,320 | 439 | / | EU643618.1 | ( | ||
|
| / | 1,170 | 382 | 70 | KR062001.1 | ( | |
| Δ4 |
| 34 % to DPA | 1,302 | 433 | 48.1 | JQ664598.1 | ( |
|
| 79.8 to DPA | 1,284 | 427 | 47.9 | JQ791105.1 | ( | |
|
| 10% to DPA, 4% to DTA | 1,409 | 459 | / | XM_001415706.1 | ( | |
|
| ~30% to DPA and DTA | 1,619 | 445 | 49 | AAQ98793.1 | ( | |
|
| / | 1,440 | 479 | 52.7 | GU594191.1 | ( |
The effect of site directed mutagenesis on the performance of desaturase.
|
|
|
|
|
|
|---|---|---|---|---|
| Δ9-desaturase |
| F160L, A223T, and L156M | Substrate preference changes from C16:0 to C18:0 | ( |
| Δ12-desaturase |
| P166L or H116Y | Loss the catalytic activity from 18:1Δ9 to 18:2Δ9,12 | ( |
| Δ12-desaturase |
| W131L or S218G or N389D | Activity weakened slightly | ( |
| Δ6-desaturase |
| F419V or A374Q | Activity decreases to the half of wild type | ( |
| Q409R or M242P | Completely inactivated | ( | ||
| Q236N or A423C | Activity enhanced slightly | ( | ||
| Q190A, S197Q, and Q209G | No significant change | ( | ||
| V399I/I400E, E222S, and M227K | Activity decreases to 40.26, 31.42, and 31.61%, respectively (wild type: 71.37%). | ( | ||
| G194L | Activity decreases to 6.5%, respectively (wild type: 71.37%). | ( | ||
| Δ15-desaturase |
| T286S | No significant change | ( |
| T286Y, T286H, T286C, or T286G | Loss of catalytic activity | ( | ||
|
| E111D, T322S, and F353H | No significant change to wild type | ( | |
| W106F and V137T | Markedly decreased the conversion rate for AA (40 to 50%) | ( | ||
| A44S, M156I, and W291M | Markedly increase the conversion rate for AA (30–40%) | ( |
The characteristic of the ω3-desaturase.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| Δ15 | / | 1,845 | 433 | 49.2 | GQ888689.1 | ( | |
|
| 59.7% to LA, 29.6% to AA | 1,212 | 403 | KF433065.1 | ( | ||
|
| 3.4% to LA, 4.2% to GLA | 1,587 | 403 | / | KY399781.1 | ( | |
| Δ17 |
| 63.8% to AA | 1,533 | / | / | FW362186.1 | ( |
|
| 60% to AA | 1,092 | / | / | FW362213.1 | ( | |
|
| 65% to AA | 1,086 | / | / | FW362214.1 | ( |
The characteristic of the elongase.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| Δ6 |
| 24 to GLA 41 to SDA | 1,331 | 288 | 29.9 | EU846098.1 | ( |
| 29.3 to GLA | 837 | 277 | 32.1 | KJ546459.1 | ( | ||
|
| 70.5 to GLA 34.6 to SDA | 831 | 276 | / | KY214452.1 | ( | |
| Δ5 |
| 30.2 to EPA | 1,220 | 302 | / | AY926605.1 | ( |
|
| / | 1,228 | 314 | 34 | EF486525.1 | ( | |
|
| 87.9 to EPA | 1,110 | 369 | / | XP_002176686.1 | ( |
Figure 2The crystal structure of transmembrane fatty acid desaturases. (A), crystal structure of mouse stearoyl-CoA desaturase (PDB ID: 4YMK). (B), human integral membrane stearoyl-CoA desaturase (PDB ID: 4ZYO).